Publications

Pubmed logo      Google Scholar

Select publications

  1. Herbst-Kralovetz MM, Radtke AL, Lay MK, Hjelm BE, Bolick AN, Sarker SS,Atmar RL, Kingsley DH, Arntzen CJ, Estes MK, Nickerson CA. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis. 2013 Mar;19(3):431-8.doi: 10.3201/eid1903.121029.

  2. Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM (2011) Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 29: 32,5221-31

  3. Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, ChenQ, Mason HS, Herbst-Kralovetz MM. (2011) A non-replicating subunit vaccine protects mice against lethal Ebola virus challenge. ProcNatlAcadSci U SA. 2011 Dec 20;108(51):20695-700. Epub 2011 Dec 5. PMID:22143779

  4. Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, Whaley KJ, Arntzen CJ, Mason HS, Chen Q (2010) High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system.,Biotechnology and Bioengineering, 106 (1), 9-17

  5. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q,Mason HS (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles., Vaccine, 26 (15), 1846-54


2006

  1. L Santi, A Giritch, C Roy, S Marillonnet, V Klimyuk, Y Gleba, R Webb, Charles Arntzen, H Mason. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA (2006).

  2. Santi, L, Giritch, A, Roy, C, Marillonnet, S, Klimyuk, V, Gleba, Y, Webb, R, Arntzen, Charles, Mason, H. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system (2006).


2005

  1. Charles Arntzen, Stanley Plotkin, Betty Dodet. Plant-derived vaccines and antibodies: Potential and Limitations. Vaccine (2005).

  2. J Bryan, B Maloney, Naokazu Takeda, Yuriko Suzaki, Ami Yasushi, Tian Li, Tatsuo Miyamura, Charles Arntzen, Hugh Mason. Challenges in creating a vaccine to prevent hepatitis E. Vaccine (2005).

  3. Y Thanavala, M Mahoney, S Pal, A Scott, L Richter, N Natarajan, P Goodwin, Charles Arntzen, H Mason. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci., U.S (2005).

  4. Z Huang, L Santi, K LePore, J Kilbourne, Charles Arntzen, H Mason. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine (2005).

  5. Thanavala, Y, Mahoney, M, Pal, S, Scott, A, Richter, L, Natarajan, N, Goodwin, P, Arntzen, Charles, Mason, H. Immunogenicity in humans of an edible vaccine for hepatitis B (2005).

  6. Thanavala, Y, Maoney, M, PaL, S, Scott, A, Richter, L, Natarajan, N, Goodwin, P, Arntzen, Charles, Mason, H. Immunogenicity in Humans of an Edible Vacine for Hepatitis B (2005).


2004

  1. M Rigano, M Alvarez, J Pinkhasov, Y Jin, F Sala, Charles Arntzen, A Walmsley. Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabadopsis thaliana. Plant Cell Rep (2004).

  2. N Matoba, A Magerus, B Geyer, Y Zhang, M Muralidharan, A Alfsen, Charles Arntzen, M Bomsel, T Mor. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc Natl Acad Sci USA (2004).

  3. R Peterson, Charles Arntzen. On risk and plant-based pharmaceuticals. TRENDS in Biotechnology (2004).

  4. Book chapter: Mason, H S (Author) ,Chikwamba, R (Author) ,Santi, L (Author) ,Mahoney, R T (Author) ,Arntzen, Charles (Author) . Antigen delivery systems: Transgenic plants for mucosal vaccines. Mucosal Immunology. Elsevier Science (2004).

  5. Book chapter: Mor, T S (Author) ,Mason, H S (Author) ,Kirk, D D (Author) ,Arntzen, Charles (Author) ,Cardineau, G A (Author) . Plants as Production and Delivery Vehicle for Orally Delivered Subunit Vaccines. New Generation Vaccines. Marcel Dekker, Inc (2004).


2003

  1. Arntzen, Charles, Pitman, S. Biotechnology. Encyclopedia of Food and Culture. Charles Scribner's Sons / The Gale Group Publishers (2003).

  2. A Walmsley, Charles Arntzen. Plant cell factories and mucosal vaccines. Current Opinions in Biotechnology (2003).

  3. A Walmsley, M Alvarez, Y Jin, D Kirk, S Lee, J Pinkhasov, M Rigano, Charles Arntzen, H Mason. Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep (2003).

  4. Charles Arntzen, A Coglan, B Johnson, J Peacock, M Rodemeyer. GM Crops: Science, Politics and Communication. Nature Reviews Genetics (2003).

  5. M Rigano, F Sala, Charles Arntzen, A Walmsley. Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites. Vaccine (2003).

  6. M Smith, L Ricther, Charles Arntzen, M Shuler, H Mason. Structral characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine (2003).


2002

  1. H Mason, H Warzecha, T Mor, Charles Arntzen. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. TRENDS in Molecular Medicine (2002).

  2. T Ganapathi, V Haridas, J Gutterman, Charles Arntzen. Metabolomics of plant saponins; Bioprospecting triterpene glycoside diversity with respect to mammalian cell targets. OMICS: Journal of Integrative Biology (2002).


2001

  1. Charles Arntzen. Agricultural biotechnology. J. Sci. Food Agric (2001).

  2. Charles Arntzen, I Chalmers. The risks and rewards of biotechnology. Gastronomica (2001).

  3. M Hanausek, P Ganesh, Z Walaszek, Charles Arntzen, T Slaga, J Gutterman. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model. Proc. Natl. Acad. Sci. USA (2001).

  4. Q Kong, L Richter, Y Yang, Charles Arntzen, H Mason, Y Thanavala. Oral Immunization with hepatitis B antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA (2001).

  5. T Ganapathi, N Higgs, P Balint-Kurti, Charles Arntzen, G May, J Van Eck. Agrobacterium-mediated transformation of embryogenic cell suspensions of the banana cultivar Rasthali (AAB). Plant Cell Reports (2001).

  6. T Mor, M Sternfeld, H Soreq, Charles Arntzen, H Mason. Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnology and Bioengineering (2001).

  7. V Haridas, Charles Arntzen, J Gutterman. Avicins, a family of triterpenoid saponins from Acacia victoriae (Betham), inhibit activation of nuclear factor-B by inhibiting both its nuclear localization and ability to bind DNA. Proc. Natl. Acad. Sci. USA (2001).

  8. V Haridas, M Higuchi, G Jayatilake, D Bailey, K Mujoo, M Blake, Charles Arntzen, J Gutterman. Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation. Proc. Natl. Acad. Sci. USA (2001).

  9. Hanausek, M, Ganesh, P, Walaszek, Z, Arntzen, Charles, Slaga, T, Gutterman, J. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model (2001).

  10. Haridas, V, Arntzen, Charles, Gutterman, J. Avicins, a family of triterpenoid saponins from Acacia victoriae (Betham), inhibit activation of nuclear factor-?B by inhibiting both its nuclear localization and ability to bind DNA (2001).

  11. Haridas, V, Higuchi, M, Jayatilake, G, Bailey, D, Mujoo, K, Blake, M, Arntzen, Charles, Gutterman, J. Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation (2001).

  12. Kong, Q, Richter, L, Yang, Y, Arntzen, Charles, Mason, H, Thanavala, Y. Oral Immunization with hepatitis B antigen expressed in transgenic plants (2001).


2000

  1. A Walmsley, Charles Arntzen. Plants for delivery of edible vaccines. Current Opinion in Biotechnology (2000).

  2. C Tacket, H Mason, G Losonsky, M Estes, M Levine, Charles Arntzen. Human immune responses to a Novel Norwalk virus vaccine delivered in transgenic potatoes. The Journal of Infectious Diseases (2000).

  3. Charles Arntzen. Agricultural biotechnology. SCN News: Nutrition and Agriculture (2000).

  4. Charles Arntzen. Plant-Derived Oral Vaccines: From Concept to Clinical trials In: International Seminar on Nuclear War and Planetary Emergencies 25th Session. World Scientific Publishing Co,Singapore (2000).

  5. Charles Arntzen, D Kirk. Vaccination. McGraw-Hill Yearbook of Science & Technology (2000).

  6. L Richter, Y Thanavala, Charles Arntzen, H Mason. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnology (2000).

  7. N Bosque-Pérez, G May, Charles Arntzen. Applicability of an Agrobacterium-based system for the transformation of Musa species with diverse genomic constitution and ploidy level. Acta Horticulturae (2000).